Table 7 Comparison with data from VARA-I
From: Pattern of use of radiotherapy for lung cancer: a descriptive study
Dose (%) | Associated CT (%) | Stage (%) | Intent (%) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VARA′04 | VARA ′07 | VARA′04 | VARA ′07 | VARA′04 | VARA′07 | VARA′04 | VARA´07 | |||||||
NSCLC R | <60 Gy | 147 (77.4) | 136 (27.5) | No | 106 (25.9) | 189 (31) | NSCLC | I/II/III | 332 (90) | 415 (84) | NSCLC | R | 212 (63.1) | 274 (55.4) |
≥60 Gy * | 43 (22.6) | 358 (72.5) | Yes ** | 303 (74.1) | 421 (69) | IV # | 37 (10) | 79 (16) | P ## | 124 (36.9) | 220 (44.6) | |||
SCLC R | <45 Gy | 33 (54.1) | 1 (1.2) | SCLC | LS | 54 (79.1) | 82 (71) | SCLC | R | 54 (79.1) | 82 (71) | |||
≥45 Gy * | 28 (45.9) | 115 (98.8) | ES § | 14 (20.9) | 34 (29) | P § | 14 (20.9) | 34 (29) | ||||||
Age (years) § | Gender (%) | ECOG (%) | Radiation rate (%) * | |||||||||||
VARA′04 | VARA′07 | VARA′04 | VARA′07 | VARA′04 | VARA´07 | VARA´04 | VARA′07 | |||||||
64,6 ± 10,7 | 66 ± 10 | ♀ | 33 (8) | 55 (9) | 0 §§ | 94 (39.8) | 141 (43.9) | 416 (16) | 610 (20) | |||||
♂ ^ | 383 (92) | 555 (91) | 1 | 85 (36) | 131 (40.7) | |||||||||
2 | 36 (15.3) | 40 (12.5) | ||||||||||||
3 | 18 (7.6) | 7 (2.2) | ||||||||||||
4 | 3 (1.3) | 2 (0.7) | ||||||||||||